補體因子I(CFI)重組蛋白
Recombinant Complement Factor I (CFI)
CF-I; C3b-INA; FI; IF; KAF; Factor I; Konglutinogen-Activating Factor; C3b-Inactivator; C3B/C4B inactivator
- 編號RPB978Hu01
- 物種Homo sapiens (Human,人) 相同的名稱,不同的物種。
- 來源原核表達
- 宿主E.coli
- 內毒素水平<1.0EU/µg(LAL法測定)
- 亞細胞定位分泌, 細胞外基質
- 預測分子量28.8kDa
- 實際分子量30kDa(差異分析請參閱說明書)
- 片段與標簽Ile340~Val583 with N-terminal His Tag
- 緩沖液成份20mM Tris, 150mM NaCl緩沖液(pH8.0, 含有1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose和Proclin300)
- 性狀凍干粉
- 純度> 97%
- 等電點6.4
-
應用
Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白,請參見活性蛋白。 - 下載 英文說明書 中文說明書
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價格 ¥ 1032 ¥ 2580 ¥ 5160 ¥ 15480 ¥ 38700
- 欲了解實際交易價格和更多情況,請與當?shù)亟?jīng)銷商聯(lián)系!
序列
用法
Reconstitute in 20mM Tris, 150mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲存
避免反復凍融。2-8°C不超過一個月,-80°C不超過12個月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定,具體方法如下:在37°C孵育48小時,沒有顯著的降解或者沉淀產(chǎn)生。保質期內,在適當?shù)臈l件下存儲,損失率低于5%。
增值服務
相關產(chǎn)品
編號 | 適用物種:Homo sapiens (Human,人) | 應用(僅供研究使用,不用于臨床診斷!) |
RPB978Hu02 | 補體因子I(CFI)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPB978Hu01 | 補體因子I(CFI)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
PAB978Hu01 | 補體因子I(CFI)多克隆抗體 | WB; IHC; ICC; IP. |
PAB978Hu02 | 補體因子I(CFI)多克隆抗體 | WB; IHC; ICC; IP. |
MAB978Hu22 | 補體因子I(CFI)單克隆抗體 | WB; IHC; ICC; IP. |
WEB978Hu | 補體因子I(CFI)檢測試劑盒(酶聯(lián)免疫吸附試驗法,寬范圍) | Enzyme-linked immunosorbent assay for Antigen Detection. |
SEB978Hu | 補體因子I(CFI)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMB978Hu | 補體因子I(CFI)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻
雜志 | 參考文獻 |
J Thromb Haemost | A case report of thrombotic microangiopathy without renal involvement carrying two novel mutations in complement-regulator genes [PubMed: 26613809] |
Pediatr Int | Atypical hemolytic uremic syndrome: Korean pediatric series [PubMed: 25443527] |
United States Patent Application? | NOVEL ASSAY [y2016:139118] |
Researchgate | Compliment factor i bioassay [US20170285024] |
PLoS One | A monoclonal antibody targeting amyloid β (Aβ) restores complement factor I bioactivity: Potential implications in age-related macular degeneration and?… [Pubmed:29782502] |
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE | The importance of sialic acid, pH and ion concentration on the interaction of uromodulin and complement factor H [33788378] |
留言咨詢